SNDL Posts Record $20M Q3 Free Cash Flow, Floats $50M Buyback Bid
SNDL is trading near its 52-week low of $1.13 (13% above the low).
Summary
SNDL reported record quarterly free cash flow of $20M and positive adjusted operating income for Q3 2026, on revenue of C$238M, the first real evidence its cash-generation pivot is working. The headline numbers are muddied by a non-cash impairment in Cannabis Operations, which drove the C$50.8M net loss disclosed in last night's 6-K, and management is now running a strategic review of that segment — divestiture or cost reset is on the table. Alongside results the company announced a potential $50M substantial issuer bid, following the C$50M buyback bid flagged when shareholders rejected the reverse split on October 15. It also raised its Parallel stake to roughly 92%, deepening U.S. exposure. The Nasdaq listing overhang remains unresolved after the failed split vote, so cash flow and buyback execution are the story now. Q4 delivery on margins and the outcome of the Cannabis Ops review are the next checkpoints.
At the time of this announcement, SNDL was trading at $1.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $312.6M. The 52-week trading range was $1.13 to $2.34. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.